Multiple previously reported CLL driver mutations were identified in RT-2 including XPO1, POT1, KRAS, and TP53 [11], which have been shown to be more commonly mutated in RT when compared to CLL/SLL [18]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.